Neurology Minute
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1
Aug 15, 2024
In this insightful discussion, Dr. Dan Ackerman, a cardiac monitoring and anticoagulation expert, joins Dr. Luciano A. Sposato, a specialist in embolic stroke of undetermined sources. They explore the challenges in treating embolic stroke of undetermined source (ESUS) and the ongoing controversies regarding monitoring strategies. The conversation highlights the need for improved preventive measures and questions current treatment approaches, making it a vital listen for those in the medical field.
02:33
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Embolic stroke of undetermined sources (ESUS) represents a major clinical challenge, accounting for 20% of ischemic strokes despite extensive evaluations.
- The ongoing debate around the treatment of ESUS emphasizes the need for further research into effective prevention strategies for these strokes.
Deep dives
Prevalence and Recurrence of Embolic Stroke of Undetermined Source
Embolic stroke of undetermined source (ESUS) is a prevalent condition, accounting for approximately 20% of all ischemic stroke and transient ischemic attack (TIA) cases, despite thorough stroke workups. This high incidence highlights the clinical challenge faced by healthcare professionals in diagnosing and treating these patients. Additionally, the recurrence rate for ESUS is notably high, estimated at 4% to 5% annually, which raises concerns regarding long-term management and prevention strategies. The lack of an effective treatment option, especially when randomized controlled trials have demonstrated no advantage of anticoagulation over antiplatelet therapies, complicates the approach to these patients.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
